SG/CALL/STRYKER CORP./320/0.1/20.09.24 Share Price

Warrant

DE000SW1Y191

Market Closed - Börse Stuttgart 08:47:35 28/06/2024 BST
2.63 EUR +2.33% Intraday chart for SG/CALL/STRYKER CORP./320/0.1/20.09.24
Current month-4.36%
1 month+4.37%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
28/06/24 2.63 +2.33%
27/06/24 2.57 -2.65%
26/06/24 2.64 +6.88%
25/06/24 2.47 -10.18%
24/06/24 2.75 +3.38%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 08:47 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SW1Y19
ISINDE000SW1Y191
Date issued 07/08/2023
Strike 320 $
Maturity 20/09/2024 (83 Days)
Parity 10 : 1
Emission price 2.1
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.83
Lowest since issue 0.99
Spread 0.05
Spread %1.74%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
340.2 USD
Average target price
372.9 USD
Spread / Average Target
+9.61%
Consensus